Advanced manufacturing company Titomic Limited has entered into a scheme implementation deed to redomicile its corporate structure to the United States, in a move the company says is aimed at supporting its manufacturing and defence industry growth strategy, according to an announcement from Titomic.
Under the proposed scheme, Titomic Limited and its subsidiaries would transition to a Delaware-incorporated parent company, Titomic, Inc., while retaining its ASX presence through CHESS Depositary Interests that would continue trading under the code “TTT”.
If approved, shareholders would receive a beneficial interest in one share of Titomic, Inc. common stock for every 25 shares held in Titomic Limited, with their proportional economic interest expected to remain unchanged, subject to certain conditions.
The company said the board and management structure would remain unchanged following implementation, and the transaction would also extend to option holders and performance rights holders on a proportional basis, subject to agreements being finalised.
The scheme is subject to shareholder approval, Federal Court of Australia approval, and other regulatory clearances including ASIC, ASX and tax-related approvals. An independent expert, RSM Corporate Australia Pty Ltd, has been appointed to assess whether the scheme is in the best interests of shareholders, with its report to be included in a Scheme Booklet expected in early July 2026.
Titomic’s board has unanimously recommended that shareholders vote in favour of the scheme, subject to the independent expert continuing to conclude it is in shareholders’ best interests and no superior proposal emerging.
In outlining the rationale, Titomic said the proposed structure is intended to strengthen its position in the U.S. defence manufacturing sector, including engagement with major contractors supporting U.S. government programs and compliance with regulatory frameworks such as ITAR export controls.
It also cited potential benefits from access to a larger investor base, improved capital market access, and possible advantages for future mergers, acquisitions or a potential U.S. listing.
A shareholder meeting is expected in late July 2026, with completion targeted for mid-August 2026, subject to conditions being met.
Legal advisers include Norton Rose Fulbright Australia and Fluet & Associates PLLC in the United States.
The content of this article is based on information supplied by Titomic Limited. For more information, please refer to the official company announcement and communications from Titomic. Please consult a licensed and/or registered professional in this area before making any decisions based on the content of this article.
